Along similar lines, the co-expression of HMGB1 in the nucleus and in the cytoplasm of malignant cells has been shown to inversely correlate with tumor infiltration by CD45RO+ memory T cells and 5-year survival rate in 72 individuals with Stage IIIB CRC (174). This evidence concerns the gene HMGB1 and neoplasm.